Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Economic assessment of pulsed dose-rate (PDR) brachytherapy with optimized dose distribution for cervix carcinoma].
Remonnay R, Morelle M, Pommier P, Haie-Meder C, Quetin P, Kerr C, Delannes M, Castelain B, Peignaux K, Kirova Y, Romestaing P, Williaume D, Krzisch C, Thomas L, Lang P, Baron MH, Cussac A, Lesaunier F, Maillard S, Barillot I, Charra-Brunaud C, Carrère MO, Peiffert D. Remonnay R, et al. Among authors: quetin p. Cancer Radiother. 2010 Jun;14(3):161-8. doi: 10.1016/j.canrad.2009.11.004. Epub 2010 Mar 4. Cancer Radiother. 2010. PMID: 20206571 Clinical Trial. French.
[Clinical and dosimetric analysis of 469 prostate cancer patients treated in France in 2005 by permanent implant brachytherapy using the Iodin 125 seeds IsoSeed Bebig: report to the French Economic committee of health products (CEPS)].
Cosset JM, Gomme S, Peiffert D, Guerif S, Labib A, Hannoun-Lévi JM, Martin P, Quétin P, Nguyen TD, Flam T, Thiounn N, Henni M, Rosenwald JC, Housset M, Pontvert D, Asselain B, Chauveinc L. Cosset JM, et al. Among authors: quetin p. Cancer Radiother. 2007 Jun;11(4):206-13. doi: 10.1016/j.canrad.2007.05.003. Epub 2007 Jun 28. Cancer Radiother. 2007. PMID: 17604675 French.
Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases.
Cutuli B, Lemanski C, Le Blanc-Onfroy M, de Lafontan B, Cohen-Solal-Le-Nir C, Fondrinier E, Mignotte H, Giard S, Charra-Brunaud C, Auvray H, Gonzague-Casabianca L, Quétin P, Fay R. Cutuli B, et al. Among authors: quetin p. Cancer Radiother. 2013 Jun;17(3):196-201. doi: 10.1016/j.canrad.2013.01.011. Epub 2013 Mar 26. Cancer Radiother. 2013. PMID: 23538041
Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98.
Carrie C, Grill J, Figarella-Branger D, Bernier V, Padovani L, Habrand JL, Benhassel M, Mege M, Mahé M, Quetin P, Maire JP, Baron MH, Clavere P, Chapet S, Maingon P, Alapetite C, Claude L, Laprie A, Dussart S. Carrie C, et al. Among authors: quetin p. J Clin Oncol. 2009 Apr 10;27(11):1879-83. doi: 10.1200/JCO.2008.18.6437. Epub 2009 Mar 9. J Clin Oncol. 2009. PMID: 19273707
[Ductal carcinoma in situ of the breast. Analysis of 882 cases].
Cutuli B, Fay R, Cohen-Solal-Le Nir C, De Lafontan B, Mignotte H, Servent V, Giard S, Auvray H, Charra-Brunaud C, Gonzague-Casabianca L, Quetin P. Cutuli B, et al. Among authors: quetin p. Presse Med. 2004 Jan 31;33(2):83-9. doi: 10.1016/s0755-4982(04)98490-4. Presse Med. 2004. PMID: 15026697 French.
54 results